Kisspeptin is a family of peptides derived from the KISS1 gene, best known for their role in regulating reproductive hormone signaling.
These peptides act primarily through the GPR54 receptor (also called the Kisspeptin receptor or KISS1R). Kisspeptin is a critical regulator of the hypothalamic-pituitary-gonadal (HPG) axis, stimulating the release of gonadotropin-releasing hormone (GnRH), which in turn influences luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It has been studied in reproductive health, fertility, and certain cancers. Kisspeptin remains experimental in most contexts and is not FDA-approved for general medical use.
How It Is Used in Research Settings
- Explored in fertility research for stimulating natural GnRH release and supporting reproductive hormone cascades.
- Studied in women undergoing IVF for improving egg maturation and ovulation induction.
- Investigated for potential roles in diagnosing and treating delayed puberty or hypogonadism.
- Examined in oncology research due to its involvement in metastasis suppression in certain cancers.
Proposed Uses (Research Areas)
- Fertility and reproductive health studies.
- Puberty and hypogonadism research.
- Oncology studies focused on metastasis inhibition.
- Neuroendocrine signaling and hormonal regulation models.
How It Is Dosed in Research Settings
- Injectable: Research protocols often use subcutaneous or intravenous administration. Doses studied range widely (20–1,000 mcg), depending on whether the focus is fertility, diagnostic stimulation, or hormonal studies.
- Cycle length: Can be single-dose administration for diagnostic purposes or repeated dosing over several days in fertility research.
- Handling: Supplied as lyophilized powder; reconstituted with bacteriostatic water and stored refrigerated per research SOPs.
Important Considerations
- Regulatory status: Kisspeptin is not FDA-approved; use remains experimental outside of controlled fertility and diagnostic research.
- Evidence base: Human clinical studies support its role in fertility and reproduction, but broader applications are still being investigated.
- Safety: Generally well tolerated in short-term research, though side effects can include flushing, nausea, or transient changes in hormone levels. Long-term safety data is limited.
Disclaimer
This material is provided for educational purposes only and summarizes published research on Kisspeptin.
It is not medical advice. Kisspeptin is experimental, not FDA-approved, and should not be viewed as a therapy for medical use.
This peptide is for research use only.